Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Exploratory Study of EVA-001 for Knee Osteoarthritis
jRCT1080225305Phase 2Recruiting
- Sponsor
- Evastem
- Start
- Aug 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of EVA-001 in knee osteoarthritis (OA), sponsored by Evastem. Started Aug 2020; status: recruiting.
02
Drugs
EVA-001
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT1080225305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080225305.